Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

112.68 +1.21 (+1.09%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

53 54 Next >

This Is Great News for Medtronic, but Is It Time to Buy the Stock? ↗

August 26, 2024

This MedTech leader is back on track with profitable growth.

Via The Motley Fool

Donald Trump Owns These 21 Dividend Kings. Should You? ↗

August 26, 2024

Some of Trump's Dividend Kings deserve a crown more than others.

Via The Motley Fool

Topics Government

3 Unstoppable Dividend Stocks to Buy Right Now ↗

August 25, 2024

These stocks are the A-team for income investors.

Via The Motley Fool

Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally

August 23, 2024

Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.

Via MarketBeat

Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗

August 22, 2024

Via Benzinga

Abbott Laboratories's Options Frenzy: What You Need to Know ↗

July 26, 2024

Via Benzinga

Abbott Laboratories, Nu Holdings And More On CNBC's 'Final Trades' ↗

August 22, 2024

Abbott Laboratories has a strong pipeline and the stock is starting to move, according to Karen Firestone of Aureus Asset Management.

Via Benzinga

Looking for Safe Dividend Income? These 3 Stocks Have Rock-Solid Payouts. ↗

August 17, 2024

These stocks pay above-average yields, and their dividend income could rise higher in the future.

Via The Motley Fool

Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108? ↗

August 12, 2024

An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver.

Via The Motley Fool

3 Stocks Retirees Should Absolutely Love ↗

August 10, 2024

All of these stocks can provide steady income to retired investors.

Via The Motley Fool

As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032

August 09, 2024

EQNX::TICKER_START (NYSE:OGEN),(NYSE:ABT),(NASDAQ:BIIB),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

Via FinancialNewsMedia

Chips, Glorious Chips! ↗

August 07, 2024

Someone's gotta make 'em, and someone's gotta buy 'em.

Via The Motley Fool

3 Dividend Growth Stocks to Buy Hand Over Fist in August ↗

August 07, 2024

There are blue-chip bargains paying large and growing dividends in the healthcare space.

Via The Motley Fool

Large Cap Biopharma And Healthcare, A Port In A Storm ↗

August 05, 2024

Healthcare and biopharma show nice gains in a volatile week.

Via Talk Markets

Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever. ↗

August 05, 2024

Recent market pressure could worsen, but that won't stop these successful businesses from raising their dividend payouts.

Via The Motley Fool

2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off ↗

August 03, 2024

Dividend stocks are great; cheap dividend stocks are better.

Via The Motley Fool

As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott ↗

August 02, 2024

Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users.

Via Investor's Business Daily

Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth ↗

August 02, 2024

Abbott Laboratories' growth rate may look comparable to Johnson & Johnson's, but in the long run it could become much higher.

Via The Motley Fool

7 Leading MedTech Stocks for Next-Gen Health Solutions ↗

July 31, 2024

With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.

Via InvestorPlace

Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow' ↗

July 31, 2024

Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut.

Via Benzinga

Topics Economy

Healthcare Stocks Are Coming On Strong In July Led By Biotech ↗

July 29, 2024

The biotech rally gained momentum in July with rotation out of technology stocks.

Via Talk Markets

Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today? ↗

July 29, 2024

NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem.

Via InvestorPlace

Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today? ↗

July 29, 2024

Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report.

Via InvestorPlace

Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know. ↗

July 29, 2024

ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage.

Via InvestorPlace

3 High-Yield Dividend Stocks That Are Looking Super Hot ↗

July 29, 2024

Discover high-yield dividend stocks offering solid returns. Learn about AbbVie, Target, and Abbott for reliable income and growth potential.

Via InvestorPlace

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 29, 2024

Via Benzinga

US Stocks Look To Extend Gains Ahead Of Key Tech Earnings, FOMC Meeting: Analyst Says This 'Could Serve As A Fundamental Catalyst For Small And Mid-Cap' ↗

July 29, 2024

Index futures trading indicates cautious optimism as traders anticipate a busy week, with a slew of earnings reports, the two-day Federal Open Market Committee meeting starting Tuesday, and Friday’s...

Via Benzinga

Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula ↗

July 29, 2024

This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts.

Via Benzinga

Topics Lawsuit

Is Beaten-Down Dexcom Stock a Buy on the Dip? ↗

July 29, 2024

The market may have overreacted to a disappointing earnings report.

Via The Motley Fool

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

July 29, 2024

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today